Updates

February 21, 2020February 21, 2020
Adding Keytruda to Chemo Slows Worsening in Advanced TNBC with PD-L1 Markers, Trial Finds

First-line treatment with Keytruda (pembrolizumab) and chemotherapy prolongs the time without disease worsening in people with advanced triple-negative breast cancer (TNBC) whose tumors are positive ... Read more
February 19, 2020February 19, 2020
Tucatinib Granted FDA Priority Review for Advanced HER2-positive Breast Cancer

The U.S. Food and Drug Administration (FDA) has granted priority review to Seattle Genetics’ application seeking approval of its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally ... Read more
February 17, 2020February 17, 2020
Tutu Project’s Pilot Program Helps Breast Cancer Patients Directly With Daily Expenses

The Tutu Project has awarded its first direct grants to patients and families battling breast cancer, as part of a new pilot program to ... Read more
February 14, 2020February 14, 2020
AutoNation Donates $720K to Breast Cancer Research Foundation

As part of its Drive Pink initiative, AutoNation has donated $720,000 to the Breast Cancer Research Foundation (BCRF) to support research aimed at disease ... Read more
February 7, 2020
Study of Treatment Aiming to Prevent Advanced Breast Cancer’s Spread to Bone Doses 1st Patient

GlycoMimetics announced that the first patient with advanced breast cancer has been dosed in a Phase 1b clinical trial investigating the ability of its small ... Read more

News

Keytruda-Mektovi Combo Deemed Safe in Early Triple Negative Breast Cancer Trial
February 6, 2020February 12, 2020
A combination of the immune checkpoint inhibitor Keytruda (pembrolizumab) and the melanoma therapy Mektovi ...
News

Researcher Awarded $462K NIH Grant to Study Effects of Endocrine Disruptors on Breast Cancer Risk in Young Women
February 3, 2020
Research efforts to understand the effects of endocrine-disrupting chemicals (EDCs) on breast cancer risk ...
News

Susan G. Komen Tissue Bank Teams with LifeOmic to Advance Breast Cancer Research
January 31, 2020January 31, 2020
A partnership between the Susan G. Komen Tissue Bank and LifeOmic, a software company, aims ...
News

Ziskin Prize Winners Will Collaborate to Further Immune Checkpoint Inhibitors for Treating Breast Cancer
January 30, 2020February 5, 2020
Two prominent breast cancer scientists will use their shared $250,000 Stand Up To Cancer ...
News

Artificial Intelligence Could Aid in Breast Cancer Screening, Study Shows
January 29, 2020January 29, 2020
An artificial intelligence model outperformed certified radiologists in diagnosing breast cancer from mammogram images, according to ...
News

Younger Women Planning Infertility Treatments Should First Receive Mammogram Screening, Study Suggests
January 27, 2020
Women under age 40 who plan to use assisted reproductive technology (ART) should first ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Phase 2 Trial of Triple Combo in Treating Advanced Breast Cancer Opening, Zymeworks Says
January 24, 2020February 6, 2020
Zymeworks announced the start of a Phase 2 trial examining its experimental cancer treatment ...
New Imaging Technique Measures Breast Cancer Metabolism
January 21, 2020February 14, 2020
A new imaging technique that uses magnetized particles to see in real time which ...
Leronlimab Combo Shows Promise for Metastatic TNBC in Early Phase 1b/2 Trial Data
January 20, 2020January 20, 2020
New Method Using Sound Waves May Stop Breast Cancer Spread in Lymph Nodes, Mouse Study Shows
January 17, 2020January 21, 2020
CytoDyn Files for FDA Breakthrough Therapy Status for Leronlimab for Metastatic TNBC
January 14, 2020January 22, 2020
Certain Genomic Tests May Soon Be Reimbursable for Breast Cancer Patients in Germany
January 13, 2020January 13, 2020

Keytruda, Imprime PGG Combo Increases Overall Survival in Metastatic Triple-negative BC, Data Show
January 10, 2020January 10, 2020
Treatment with Biothera Pharmaceutical‘s Imprime PGG appears to increase the sensitivity of chemotherapy-resistant metastatic ...
Arimidex ‘Highly Effective’ at Reducing Long-term Breast Cancer Rates in At-risk Women, Study Finds
January 8, 2020January 8, 2020
Enhertu Gets FDA Approval for Treatment of Advanced HER2-positive Breast Cancer
January 2, 2020January 3, 2020
Seattle Genetics Seeks Tucatinib’s Approval by FDA for Advanced HER2-positive Breast Cancer
December 30, 2019January 6, 2020

FDA Grants Breakthrough Therapy Status to Tucatinib for Advanced HER2-Positive Breast Cancer
December 19, 2019January 15, 2020
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Seattle ...
TAVO Boosts Responses to Keytruda in Triple-negative Breast Cancer Patients, Interim Phase 2 Data Show
December 18, 2019January 15, 2020
Dosing Complete in Phase 2 Trial Evaluating Lymfactin for BC Treatment-Associated Lymphedema
December 17, 2019January 15, 2020

News

Breast Cancer Index Identifies Women Likely to Benefit From Extended Hormone Therapy, Latest Data Show
December 16, 2019
The Breast Cancer Index, a molecular test developed by Biotheranostics, successfully identified a group ...
News

FDA Approves FoundationOne CDx as Companion Diagnostic Test for Piqray Treatment
December 11, 2019December 11, 2019
The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as ...
News

HHS Grant to Advance Breast Cancer Screenings Based on Ultrasound
December 9, 2019
A U.S. Department of Health and Human Services grant will fund research at two universities ...
News

CHMP Favors Kadcyla Approval in EU for Certain HER2-positive Early Breast Cancer Patients
December 6, 2019
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, ...
News

Weight Loss Surgery May Lower Risk of Breast Cancer, Research Suggests
December 4, 2019
Weight loss surgery may reduce the risk of developing breast cancer in obese individuals, ...
News

More Than $850M Raised for Inflammatory Breast Cancer Research
November 15, 2019November 15, 2019
Susan G. Komen, the Inflammatory Breast Cancer (IBC) Research Foundation, and the Milburn Foundation ...
News

Fertility Clinics and Breast Cancer ‘Previvor’ Team Up to Raise Awareness About Genetic Risk of Disease
November 13, 2019
For patients with gene mutations that increase their risk for diseases such as breast ...
News

Blood Test May Identify Breast Cancer Years Before Symptoms Appear, Pilot Study Suggests
November 11, 2019November 11, 2019
A simple blood test – which measures antibodies against certain tumor proteins, or antigens ...
News

Most Breast Cancers Found by Hand, MammaCare Researchers Say
November 8, 2019November 8, 2019
Decades after establishing the recognized standard for performing and teaching clinical and personal breast ...
News

First Patient Dosed in Phase 3 Trial of Tucatinib-Kadcyla Combo for Advanced HER2-Positive Breast Cancer
November 6, 2019
A Phase 3 trial exploring a combination of Seattle Genetics‘ tucatinib plus standard Kadcyla ...
News

Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
November 4, 2019
Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact ...
News

Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
November 1, 2019December 30, 2019
Massachusetts pathologist Lija Joseph, MD, has created an innovative program that allows patients, including ...
News

Seattle Genetics’ Tucatinib Extends Survival Outcomes in Metastatic HER2-positive Breast Cancer Patients, Phase 2 Trial Shows
October 30, 2019
People with HER-positive advanced breast cancer who received multiple HER-targeted therapies have significantly better ...
News

FDA Supports Use of Anti-diarrheal Medications with Nerlynx
October 28, 2019October 28, 2019
The U.S. label of Nerlynx (neratinib), a treatment for early stage HER2-positive breast cancer, now includes ...
News

Bempegaldesleukin-Opdivo Combo Leads to Prolonged Responses in TNBC Patients, Phase 1/2 Trial Shows
October 25, 2019November 11, 2019
Bempegaldesleukin (bempeg, NKTR-214) in combination with Opdivo (nivolumab) leads to prolonged treatment responses in ...
News

Daiichi Sankyo Files New Drug Application for DS-8201 in Japan
October 23, 2019October 24, 2019
Daiichi Sankyo has submitted an application to Japanese regulatory authorities asking that its investigational ...
News

Trastuzumab Deruxtecan Gets FDA Priority Review for Metastatic HER2-Positive Breast Cancer
October 21, 2019December 30, 2019
The U.S. Food and Drug Administration (FDA) has granted priority review to the application ...
News

Keytruda-chemo Combo Best for Clearing Tumors in Early TNBC, Latest Trial Data Show
October 18, 2019October 28, 2019
Adding the immunotherapy Keytruda (pembrolizumab) to chemotherapy increases the number of women with early ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest